| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cipla Limited (NSE: CIPLA)
CIPLA Technical Analysis
2
| As on 24th Apr 2024 CIPLA SHARE Price closed @ 1398.20 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1230.77 & Sell for SHORT-TERM with Stoploss of 1446.95 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CIPLASHARE Price
| Open | 1353.45 | Change | Price | % |
| High | 1401.90 | 1 Day | 51.50 | 3.82 |
| Low | 1352.20 | 1 Week | 23.00 | 1.67 |
| Close | 1398.20 | 1 Month | -83.05 | -5.61 |
| Volume | 4415480 | 1 Year | 495.20 | 54.84 |
| 52 Week High 1266.45 | 52 Week Low 862.35 | ||||
| CIPLA CURRENT MONTH FUTURE | |||
| Close | 1396.55 | ||
| Contracts Traded | 3786250 | ||
| Open Intrest | 4597450 | ||
| Change In O.I | -21.88 % | ||
| Lot Size | 650 | ||
| CIPLA CURRENT MONTH OPTION | |
| Most Active Call | 1400.00 |
| Most Active put | 1350.00 |
| Highest O.I Buildup Call | 1500.00 |
| Highest O.I Buildup Put | 1450.00 |
| Expiry Date | 2024-04-25 |
| CIPLA ALL MONTHS OPTIONS | |||
| For All CIPLA Options Click Here | |||
NSE INDIA Most Active Stocks
| IDEA | 13.10 | -9.03% |
| SAIL | 164.65 | 8.14% |
| YESBANK | 25.45 | -0.78% |
| TATASTEEL | 165.55 | 2.73% |
| IRFC | 149.00 | 0.85% |
| SOUTHBANK | 29.10 | 1.04% |
| MRPL | 248.70 | 10.75% |
| SUZLON | 41.80 | -0.12% |
| BEL | 236.50 | 0.92% |
| RAMASTEEL | 14.00 | 2.56% |
NSE INDIA Top Gainers Stocks
| ROML | 63.05 | 19.98% |
| COMPUSOFT | 35.20 | 19.93% |
| SHRADHA | 78.55 | 19.83% |
| STEELCITY | 102.95 | 19.78% |
| WEIZMANIND | 142.25 | 19.59% |
| TEMBO | 240.90 | 18.61% |
| CHENNPETRO | 1075.00 | 15.82% |
| YUKEN | 1180.65 | 13.81% |
| ORIENTCEM | 230.50 | 12.85% |
| AEGISCHEM | 604.50 | 12.41% |
NSE INDIA Top Losers Stocks
| CIPLA Daily Charts |
CIPLA Intraday Charts |
Whats New @ Bazaartrend |
CIPLA Free Analysis |
|
|
CIPLA Important Levels Intraday
| RESISTANCE | 1493.97 |
| RESISTANCE | 1463.26 |
| RESISTANCE | 1444.27 |
| RESISTANCE | 1425.29 |
| SUPPORT | 1371.11 |
| SUPPORT | 1352.13 |
| SUPPORT | 1333.14 |
| SUPPORT | 1302.43 |
CIPLA Target April 2024
| 4th UP Target | 1906.59 |
| 3rd UP Target | 1766.86 |
| 2nd UP Target | 1680.49 |
| 1st UP Target | 1594.12 |
| 1st DOWN Target | 1347.68 |
| 2nd DOWN Target | 1261.31 |
| 3rd DOWN Target | 1174.94 |
| 4th DOWN Target | 1035.21 |
CIPLA Weekly Target
| 4th UP Target | 1577.57 |
| 3rd UP Target | 1503.22 |
| 2nd UP Target | 1457.27 |
| 1st UP Target | 1411.31 |
| 1st DOWN Target | 1280.19 |
| 2nd DOWN Target | 1234.23 |
| 3rd DOWN Target | 1188.28 |
| 4th DOWN Target | 1113.93 |
CIPLA Target2024
| 4th UP Target | 2077.9 |
| 3rd UP Target | 1811.2 |
| 2nd UP Target | 1646.35 |
| 1st UP Target | 1481.49 |
| 1st DOWN Target | 1011.11 |
| 2nd DOWN Target | 846.25 |
| 3rd DOWN Target | 681.4 |
| 4th DOWN Target | 414.7 |
Cipla Limited ( NSE INDIA Symbol : CIPLA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CIPLA Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 37.27 | Sideways | |
| MFI (14) | MFI is 54.26 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -73.69 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 457.11 | |
| 10 Day Avg Volume | Traded -22.88 % Less then 10 Day Average Volume | ||
CIPLA Other Details
| Segment | EQ | |
| Market Capital | 737442988032.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-General | |
| Offical website | > | |
CIPLA Address
 |
||
CIPLA Latest News
CIPLA Business Profile
Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. It also provides respiratory products, including inhalers and nasal sprays, as well as other dosage forms consists of injectables and biosimilars. Cipla Limited has collaboration with CSIR-Indian Institute of Chemical Technology for the development of medication for the treatment of COVID-19; partnership with Karwa Ltd. for the commercialization of antibody detection kits for COVID-19; partnership with the Premier Medical Corporation Private Limited for the commercialization of the rapid antigen test kits for COVID-19; licensing agreement with Merck & Co., Inc. for the manufacturing and distribution of Molnupiravir, an investigational oral antiviral drug; license agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib for Covid-19 indication; and collaborations with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for the clinical trial of the investigational oral anti-viral drug Molnupiravir. The company was incorporated in 1935 and is headquartered in Mumbai, India. Address: Cipla House, Mumbai, India, 400013
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service